Investors & Media International Stem Cell Corporation Presents Comprehensive Findings for Parkinson's Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015 International Stem Cell Corporation Develops Technology to Replace Cartilage for the Treatment of Osteoarthritis International Stem Cell Names Ms. Ebrahimi as Chief Financial Officer International Stem Cell Corporation Announces Next Phase of Research Collaboration With Rohto Pharmaceutical Co., Ltd. of Japan International Stem Cell Corporation to Present at the Rodman and Renshaw Global Investment Conference ISCO Appears in San Diego Business Journal International Stem Cell Corporation Announces Record Net Income in Second Quarter 2015 International Stem Cell Corporation Completes Clinical Testing of a New Compound International Stem Cell Corporation Submits Remaining Requested Safety Study Report for Clinical Trial Authorization International Stem Cell Corporation Announces 1:150 Reverse Stock Split 3 4 5 6 7 8 9 10 11 12 13 << < > >>
